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ABSTRACT 
 
Unilateral absence of lung tissue and bronchial tree is an uncommon congenital abnormality. 
Previous reports have estimated an incidence of 1 in 15,000 pregnancies but accurate data 
has not been available. Here, we use the North of England register of congenital anomalies 
(NorCAS) to calculate the incidence as 0.12 per 100,000 live births (95% confidence interval 
0.03-0.31). We briefly report the course of the four patients with this condition born in the 
region between 2004 and 2013. Contrary to previous reports, the medium term outcomes in 
our patients have been good, even when lung agenesis is associated with other congenital 
anomalies such as congenital heart disease. Long-term prognosis with modern management 
remains unknown. 
 
INTRODUCTION 
 
Lung agenesis is a rare congenital anomaly in which failure of the embryological lung bud to 
develop results in unilateral absence of lung tissue and the bronchial tree. [1] Recent 
literature has quoted an estimated incidence of 1 in 15,000 pregnancies but accurate 
incidence data has not previously been available. [2] 
Prognosis is also uncertain but is generally reported as poor in older literature, especially 
when lung agenesis is associated with anomalies in other organs. [2]  A recent systematic 
review identified a total of 96 cases of lung agenesis reported in the years 1993 to 2013. [3] 
All 23 cases where this was an isolated anomaly were alive at the time of reporting apart 
from one case which underwent termination of pregnancy. Outcomes in the 73 cases 
associated with other anomalies were more variable: just under half (35 patients) were alive 
at the time of reporting, with 27 reported to have died, 2 terminations of pregnancy and 9 
cases where outcome was not reported. The most common other anomaly was congenital 
heart disease but there was a wide-range of associations including tracheal, skeletal, renal, 
gastrointestinal and facial defects.  
 
The North of England has a registry of congenital anomalies – the Northern Congenital 
Abnormality Survery (NorCAS) - which routinely collects prospective data on all congenital 
malformations. [4] There is also a centralised tertiary respiratory paediatric service which 
manages all confirmed cases of lung agenesis. We were therefore able to identify and 
follow-up all cases in order to more accurately report the incidence and contemporary 
outcomes of this rare condition. 
 
METHODS 
 
The NorCAS database records all cases of congenital anomalies detected from prenatal 
diagnosis to age 12 in the population of the North of England, as previously described. [4] 
The database was interrogated to find cases of pulmonary agenesis between 2004 and 2013 
together with figures for all live births. Case notes were reviewed. Parents or carers of all 
patients provided signed consent for publication of anonymous case summaries. Confidence 
intervals for Poisson rates were calculated using the EpiTools package for R. 
 
RESULTS 
 
Incidence 
 
Between the years 2004 to 2013 there were 328,842 live born infants in the North of 
England and 4 infants born with lung agenesis, giving an incidence of 0.12 per 100,000 live 
births (95% confidence interval 0.03-0.31). In addition, one pregnancy with an antenatal 
diagnosis underwent termination of pregnancy. 
 
Case Reports 
 
Case 1: Agenesis of the left lung was noted at the 20 week anomaly scan along with 
complex heart defects (complete atrioventricular septal defect with left atrial isomerism but 
normal spleen, transposed great arteries, right aortic arch and pulmonary stenosis). The 
baby was born in good condition at term. At three weeks of age she was readmitted with low 
oxygen saturations and underwent central shunt insertion (left subclavian artery to main 
pulmonary artery), which provided an adequate circulation until two years of age when she 
underwent corrective surgery. 
 
Bronchoscopy revealed absence of complete tracheal rings, a blind ending stump to left 
main bronchus and moderate malacia of the right main bronchus. The patient has 
subsequently had multiple lower respiratory tract infections and received booster 
vaccinations after low specific titres were noted. Prophylactic antibiotics have also been 
prescribed. The patient is currently 7 years old and in mainstream schooling. Her mean 
oxygen saturations are 98% in air; spirometry at 6 years showed FEV1 53% predicted with 
FVC 54% predicted. 
 
Case 2: Right lung aplasia was noted on MRI at 28 weeks while investigating abnormal 
cardiac views seen at the 20 week anomaly scan. The baby was born at term and did not 
require resuscitation. Postnatal echocardiograms confirmed coarctation of the aorta 
(repaired at 9 days) and an atrial septal defect (ASD; repaired at 3 months). The patient 
subsequently developed Wolff-Parkinson-White syndrome and underwent accessory 
pathway ablation at 6 years of age. 
 
Previous reports have highlighted an association between lung aplasia and pulmonary 
hypertension; this seems to particularly occur with right-sided defects. [2] Our patient was 
treated for pulmonary hypertension following ASD repair, but treatment was discontinued 
after 3 months. The patient also had several urinary tract infections associated with Grade 1 
vesicoureteral reflux but structurally normal kidneys. She is currently 10 years old and 
generally well, even taking part in charity running events. Spirometry at 8 years showed 
FEV1 of 55% predicted and FVC 56% predicted. 
 
Case 3: Absence of the left lung was diagnosed at the 20 week anomaly scan. Subsequent 
investigations revealed a number of associated problems: segmental abnormalities of 
thoracic vertebrae 5 to 7 causing scoliosis, together with a dysplastic left thumb and bilateral 
grade 2 vesicoureteral reflux associated with recurrent urinary tract infections. This last 
problem is being managed with prophylactic antibiotics. Cardiac anatomy was normal other 
than an absent left pulmonary artery. Bronchoscopy at 15 months showed no evidence of 
bronchial stump on the left and normal right-sided anatomy. 
 
The baby was born at term and required oxygen therapy shortly after birth. The subsequent 
clinical course has been dominated by recurrent lower respiratory tract infections. The 
patient was initially discharged home without oxygen but required continuous oxygen 
following a respiratory infection at 14 months: this was gradually weaned and stopped at age 
2 years 10 months. The patient is currently 3 years old and doing well. 
 
Case 4: This patient was born by spontaneous vaginal birth after an uncomplicated 
pregnancy with no antenatal concerns. She was initially well but was readmitted on day 2 of 
life with poor feeding and tachypnoea. Saturations were 86-88% in air. Chest x-ray revealed 
absence of the left lung. She was discharged with home oxygen and made good progress 
other than several short admissions for respiratory tract infections. Echocardiogram showed 
a structurally normal heart and no evidence of pulmonary hypertension. Oxygen was 
gradually weaned and stopped after normal nocturnal saturation studies at 2 years of age. 
 
DISCUSSION 
 
Here we report the first accurate estimate of the incidence of congenital lung agenesis, 
which appears to be lower than previously estimated at 0.12 per 100,000 live births. 
Currently there are no known environmental associations with this condition and it is 
therefore presumed to be sporadic, suggesting the incidence will be relatively stable across 
comparable populations. 
 
Medium-term outcomes in our patients have been more favourable than previous reports. All 
four patients have a good quality of life with no home oxygen requirement.  It is important 
that these children are managed in a service which can provide early assessment of all 
associated anomalies. Specialist involvement should begin at diagnosis, which was 
antenatally in three of the four cases reported here. This allows personalised discussion of 
prognosis and expected course, and facilitates planning of future interventions. [5]  
 
However, long-term outcome with modern management is still unknown, and a particular 
concern is the potential for the development of pulmonary hypertension in later life. We hope 
to follow-up these patients to clarify this issue.  
 
Other than cardiac abnormalities, the two main clinical problems in our patients have been 
recurrent lower respiratory tract infections and vesico-ureteric reflux. Both require meticulous 
surveillance and judicious use of antibiotics. However, it is unclear whether the incidence of 
these co-morbidities is truly higher in patients with lung agenesis compared to the normal 
population, or whether the detection rate is higher because of closer medical surveillance. 
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